Connect your AI

Envoy Medical COCH Financing Cash Flow

Financing Cash Flow at other companies

Inspire Medical SystemsINSP

-$7.48M+91.5%

Other financials

Income statement

Revenue$39.0K-15.2%

Gross profit-$274.0K-52.2%

Operating income-$6.0M-16.7%

Net income-$4.4M+12.9%

EPS (diluted)-$0.08+72.4%

Balance sheet

Cash & equivalents$25.3M+376%

Total debt$919.0K-2.8%

Total equity$10.2M+142%

Total assets$29.8M+187%

Cash flow

Operating cash flow-$6.1M-62.7%

CapEx$172.0K—

Free cash flow-$5.9M-28.5%

Valuation

Market cap$61M+83.5%

P/S260.7×+111×

Profitability

Gross margin-310.7%+31.6pp

Operating margin-9,881.2%+805pp

Net margin-9,875.6%+771pp

FCF margin-7,626.6%-652pp

Returns & leverage

Return on equity328.7%—

Debt / equity0.1×—

Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Envoy Medical's financing cash flow?: Envoy Medical (COCH) reported financing cash flow of $27.57M in Q1 2026.
How has Envoy Medical's financing cash flow changed year-over-year?: Envoy Medical's financing cash flow increased by 675.9% year-over-year, from $3.55M to $27.57M.
What is the long-term trend for Envoy Medical's financing cash flow?: Over 4 years (2021 to 2025), Envoy Medical's financing cash flow has grown at a -55.6% compound annual growth rate (CAGR), from $428.37M to $16.63M.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.